B P International

  For a long time, it was assumed that, while weight loss was necessary and desired, comorbidities were far more significant and required treatment, preferably with medication, even if weight loss was not a treatment objective. This disagreement causes therapy to be postponed, which then leads to overly extensive medical treatment. As a result, health-care expenses have risen to unacceptably high levels, resulting in the medicalization of individuals and a decline in patient responsibility for their own health, leaving it up to individuals to decide when their own weight is an issue that needs to be addressed. The goal of this study was to gather evidence to support a paradigm change in regards to the association between body weight and comorbidities. Insulin resistance is the root of the problem, which leads to a slew of other health issues. To ensure better tailor-made treatment for patients, this illness should be diagnosed at primary care and obesity clinics. Treatment for insu...

Background: Myofascial pain syndrome (MPS) is a common pain condition characterized by a key symptoms and signs, determined by multiple etiologies, comorbid with a variety of systemic diseases and regional pain syndromes (RPS) and managed by diverse integrative therapies including complementary and alternative modalities (CAM) with variable outcomes. Objective: This study aimed to concisely report 11 cases of myofascial pain syndrome managed by myofascial trigger point therapy.  Methods: The relevant information about 11 cases was collected prospectively using a semistructured proforma. All patients were diagnosed mainly by detailed history and gold standard palpation method that helps identify taut muscles, tender myofascial trigger points, local twitch response and autonomic manifestations.  Results: Most of the patients with variable age and profession presented in emergency room with acute pain, limited motion, weakness, referred pain of specific pattern and associated au...

Objective: Data on rheumatoid arthritis (RA) in Kuwait and The Middle East is scarce. Available data from Western countries may not be representative of the region. We describe RA patients in Kuwait and compare them with other RA populations and with Kuwaiti general population. Methods: Adult RA patients from Kuwait Registry for Rheumatic Diseases (KRRD), the first RA registry in The Middle East, were studied from February 2013 through February 2015. Demographic, clinical and serologic data were compared with other RA populations and with Kuwaiti general population. Results: 835 patients were enrolled, 62.3% female. Mean age 50.6±12 years and disease duration 6.1±6 years. RA was diagnosed at a mean age of 44.9±12 years. 17.1% had family history of autoimmune rheumatic diseases. 3.1% had rheumatoid nodules. Rheumatoid factor (RF) and anti-citrullinated peptide (ACPA) were detected in 75.6% and 57.8%, respectively. Both were positive in 49% (r=0.287, p=0.001). ANA was posit...